STRS OHIO - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STRS OHIO ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$769,000
+130.2%
14,900
+10.4%
0.00%
+100.0%
Q2 2022$334,000
-23.4%
13,500
-22.4%
0.00%0.0%
Q1 2022$436,000
-11.2%
17,400
+28.9%
0.00%0.0%
Q4 2021$491,000
+130.5%
13,500
+8.0%
0.00%
+100.0%
Q3 2021$213,000
-68.1%
12,500
-74.9%
0.00%
-50.0%
Q2 2021$668,000
+86.6%
49,900
+612.9%
0.00%
+100.0%
Q1 2021$358,000
-62.4%
7,000
-54.5%
0.00%
-75.0%
Q4 2020$953,000
-0.6%
15,400
-12.0%
0.00%0.0%
Q3 2020$959,000
+35.6%
17,500
+42.3%
0.00%
+33.3%
Q2 2020$707,000
+5791.7%
12,300
+4000.0%
0.00%
Q1 2020$12,0003000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2019$554,000
-28.5%
59,600
+6.8%
0.00%
-50.0%
Q1 2019$775,000
+27.5%
55,8000.0%0.00%
+33.3%
Q4 2018$608,000
-8.2%
55,800
+6.5%
0.00%0.0%
Q3 2018$662,000
-16.4%
52,400
-13.0%
0.00%0.0%
Q2 2018$792,000
+5.0%
60,200
+8.5%
0.00%0.0%
Q1 2018$754,000
+47.6%
55,500
-35.5%
0.00%
+50.0%
Q4 2017$511,000
-19.9%
86,0000.0%0.00%
-33.3%
Q3 2017$638,000
-9.6%
86,000
+13.9%
0.00%0.0%
Q2 2017$706,000
+84.8%
75,500
+43.5%
0.00%
+50.0%
Q1 2017$382,000
+16.8%
52,600
+19.0%
0.00%
+100.0%
Q4 2016$327,00044,2000.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 545,532$13,518,0005.54%
Integral Health Asset Management, LLC 574,029$14,224,0002.93%
HealthCor Management, L.P. 1,097,370$27,193,0002.73%
Logos Global Management LP 600,000$14,868,0002.73%
Cormorant Asset Management, LP 1,425,000$35,312,0002.67%
Altium Capital Management LP 160,000$3,965,0001.59%
Cahill Wealth Management, LLC 68,358$1,693,0001.43%
Hood River Capital Management LLC 1,336,776$33,125,0001.32%
Sofinnova Investments, Inc. 636,659$15,776,0001.31%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,000$121,100,0001.26%
View complete list of CHEMOCENTRYX INC shareholders